Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Allergic Reactions02:06

Allergic Reactions

28.1K
Overview
28.1K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

397
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
397
Hypersensitivities01:30

Hypersensitivities

897
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
897
Antibody Structure01:10

Antibody Structure

60.9K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
60.9K
Allergic Drug Reactions01:27

Allergic Drug Reactions

925
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
925
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

986
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
986

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Remission and Meaningful Outcomes in Chronic Rhinitis and Rhinosinusitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology·2026
Same author

Development and Validation of the Risk of Exacerbation in Severe Asthma (RESA) Model.

The journal of allergy and clinical immunology. In practice·2026
Same author

What is new on the horizon for the biologics world: New kids of the block - WAO state of art.

The World Allergy Organization journal·2026
Same author

A Link Between Allergy and Hematological Malignancies? Focus on Possible Mechanisms and the Potential Role of Biological Therapies.

Clinical and translational allergy·2026
Same author

Longitudinal observation of severe asthma comorbidities and oral corticosteroids use from SANI and ISAR registries.

The World Allergy Organization journal·2026
Same author

Former smokers with severe eosinophilic asthma respond to benralizumab as effectively as never-smokers: a <i>post hoc</i> analysis of the ANANKE study.

ERJ open research·2026
Same journal

Update of the evidence- and consensus-based S3 guideline on atopic dermatitis: Systemic therapy with biologics or Janus kinase inhibitors and specific aspects of systemic therapy in pregnancy and lactation.

Allergologie select·2026
Same journal

Resolution of childhood wheat allergy through evolution into WALDA? A case report.

Allergologie select·2026
Same journal

T-cell mechanisms in atopic dermatitis.

Allergologie select·2026
Same journal

Cefazolin as an alternative in patients with a history of penicillin or β-lactam antibiotic allergy: A case overview.

Allergologie select·2026
Same journal

Does the teicoplanin skin test predict IgE-mediated hypersensitivity?

Allergologie select·2026
Same journal

Expert consensus on the long-term use of lanadelumab in hereditary angioedema: Toward harmonized care.

Allergologie select·2026
See all related articles

Related Experiment Video

Updated: Aug 19, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K

Adherence in allergen immunotherapy: Current situation and future implications.

Francesca Gehrt1, Qingqing Xu2,3, Ilaria Baiardini4,5

  • 1Department of Otorhinolaryngology, Head and Neck Surgery, Section of Rhinology and Allergy, University Hospital Marburg, Philipps-University Marburg, Marburg, Germany.

Allergologie Select
|December 2, 2022
PubMed
Summary
This summary is machine-generated.

Allergen immunotherapy (AIT) is a key allergy treatment, but poor adherence limits its effectiveness. This review explores adherence challenges and suggests solutions for better patient compliance.

Keywords:
adherenceallergen immunotherapypersistencesubcutaneoussublingual

More Related Videos

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.4K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Related Experiment Videos

Last Updated: Aug 19, 2025

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.5K
Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

8.4K
Humanized Mediator Release Assay as a Read-Out for Allergen Potency
10:22

Humanized Mediator Release Assay as a Read-Out for Allergen Potency

Published on: June 29, 2021

3.6K

Area of Science:

  • Allergy and Immunology
  • Clinical Therapeutics

Background:

  • Allergen immunotherapy (AIT) represents the sole disease-modifying therapeutic strategy for allergic conditions.
  • Despite its efficacy, clinical trials and real-world data consistently report suboptimal patient adherence to AIT regimens.

Purpose of the Study:

  • To conduct a comprehensive review of the last decade's literature on allergen immunotherapy (AIT).
  • To identify and delineate the primary reasons contributing to poor treatment adherence in AIT.
  • To propose evidence-based strategies for enhancing patient adherence to AIT.

Main Methods:

  • Systematic literature search of publications from the past 10 years.
  • Analysis of studies focusing on patient adherence in allergen immunotherapy.
  • Synthesis of findings to identify barriers and facilitators of adherence.

Main Results:

  • Poor adherence is a significant challenge across various AIT modalities and patient populations.
  • Key barriers include complex treatment schedules, side effects, cost, and lack of patient understanding.
  • Factors influencing adherence are multifaceted, involving patient-related, treatment-related, and healthcare system-related aspects.

Conclusions:

  • Improving adherence to allergen immunotherapy is crucial for maximizing treatment efficacy and achieving long-term disease modification.
  • Addressing identified barriers through patient education, simplified protocols, and supportive care is essential.
  • Future research should focus on innovative approaches to enhance sustained adherence and long-term outcomes in AIT.